NeoMatriX® Wound Matrix

New Skin in The Game

About NeoMatriX®

NeoMatriX® Wound Matrix is fabricated from the dermal extracellular matrix of axolotl.  NeoMatriX® is provided as sheets of various sizes for placement on wound beds to help manage the wound environment.

Indications for Use

NeoMatriX® Wound Matrix is intended for the management of wounds including:












This device is terminally sterilized using gamma irradiation and is intended for one-time use.

• Partial and full-thickness wounds

• Pressure ulcers

• Venous ulcers

• Diabetic ulcers

• Chronic vascular ulcers

• Tunneled/undermined wounds

• Surgical wounds (donor sites/grafts

   post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence)

• Trauma wounds (abrasions, lacerations, second-degree burns, skin tears)

• Draining wounds

Biocompatibility & safety Testing

NeoMatriX® has been rigorously tested in accordance with recognized biocompatibility standards










• Cytotoxicity

• Sensitization

• Irritation/intracutaneous reactivity

• Acute systemic toxicity

• Pyrogenicity

• Subacute and sub-chronic toxicity

• Genotoxicity

• Endotoxin testing was conducted according to AAMI ST72

• Sterilization validation using gamma radiation to a sterility assurance level of 10-6

• Viral inactivation testing was also performed

• Pre-clinical testing showing non-inferiority in a porcine wound healing model

• Clinical testing indicating that NeoMatriX Wound Matrix does not raise     aimmunogenicity concerns when used in humans


Available in the United States late 2019



13709 Progress Blvd, Box 11

Alachua, FL 32615

Copyright 2019. All Right Reserved / MKT-001 Rev 0 / Designed By SPG